Provided By PR Newswire
Last update: Aug 9, 2024
NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HilleVax, Inc. ("HilleVax" or the "Company") (NASDAQ: HLVX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:HLVX (9/2/2025, 2:08:11 PM)
2.09
0 (0%)
Find more stocks in the Stock Screener